PIK3CA mutations contribute to fulvestrant resistance in ER-positive breast cancer.
Year: 2019
Type: article
Abstract: mutations could not only confer to fulvestrant resistance, but also promote cell proliferation and migration. Inhibition of corresponding activated pathways could effectively suppress cell growth.
Source: PubMed
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2985804592
